Vial2Bag Restrictions/Guidelines

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

8 posts / 0 new
Log in or register to post comments
Last post
Tue, 11/13/2018 - 11:27
#1
Engie Attia
Engie Attia's picture
Offline
Last seen: 1 year 11 months ago
Joined: 02/22/2018 - 13:59
Vial2Bag Restrictions/Guidelines

As our Operations team tries to be more efficient with pharmacy preparation and decreasing TAT we are moving more and more products away from pharmacy compounding and towards ADC stock via Vial2Bag. Are any institutions providing safeguards/restrictions on high alert high risk medications being supplied in ADC's via vial2bag? For example calcium gluconate vial2bag? or bivalirudin vial2bag? Are you allowing those to be stocked in your ADCs? and if so, have you been successful in adding any safeguards to prevent errors ?

Tags: 

Top